Gentamicin sulfate and Ocular hyperaemia - a phase IV clinical study of FDA data

Summary:

Ocular hyperaemia is reported as a side effect among people who take Gentamicin sulfate (gentamicin sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Natacyn, and have Conjunctivitis.

The phase IV clinical study analyzes which people have Ocular hyperaemia when taking Gentamicin sulfate. It is created by eHealthMe based on reports of 3,896 people who have side effects when taking Gentamicin sulfate from the FDA, and is updated regularly.

What is Gentamicin sulfate?

Gentamicin sulfate has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 3,942 Gentamicin sulfate users. Check the latest studies of Gentamicin sulfate.

What is Ocular hyperaemia?

Ocular hyperaemia (an abnormally large amount of blood in eye) is found to be associated with 1,356 drugs and 1,499 conditions by eHealthMe. Check the latest studies of Ocular hyperaemia.

On Jul, 16, 2026

3,896 people reported to have side effects when taking Gentamicin sulfate.
Among them, 22 people (0.56%) have Ocular hyperaemia.

Could Gentamicin sulfate cause Ocular hyperaemia?

Among these 22 people:

How long have people been on Gentamicin sulfate when they have Ocular hyperaemia? *

What is the gender of people who have Ocular hyperaemia when taking Gentamicin sulfate? *

female: 80 %
male: 20 %

What is the age of people who have Ocular hyperaemia when taking Gentamicin sulfate? *

What are other drugs people take besides Gentamicin sulfate? *

What are other side effects people have besides Ocular hyperaemia? *

Eye Pain: 8 people, 36.36%
Eye Pruritus (eye itching): 7 people, 31.82%
Eye Irritation: 7 people, 31.82%
Lacrimation Increased: 6 people, 27.27%
Foreign Body Sensation In Eyes (feeling of something in eye): 5 people, 22.73%
Visual Acuity Reduced (reduced clearness of vision): 3 people, 13.64%
Eye Discharge: 3 people, 13.64%
Hypersensitivity: 2 people, 9.09%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 2 people, 9.09%
Superficial Injury Of Eye: 2 people, 9.09%

What are the existing conditions these people have? *

Conjunctivitis (pink eye): 3 people, 13.64%
Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 2 people, 9.09%
Eye Infection: 2 people, 9.09%
Corneal Infiltrates (small hazy greyish areas of cornea): 2 people, 9.09%
Conjunctival Ulcer: 2 people, 9.09%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 1 person, 4.55%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 4.55%
Pain: 1 person, 4.55%
Ocular Rosacea (redness, irritation or burning of the eyes): 1 person, 4.55%
Hypersensitivity: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin sulfate and have Ocular hyperaemia?

- Check whether Ocular hyperaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gentamicin sulfate:

Gentamicin sulfate (3,942 reports)

Browse all side effects of Gentamicin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,356 drugs)

Browse all the conditions that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,499 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate (the active ingredients of Gentamicin sulfate) and Gentamicin sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.